EMA - Publication of a Questions and Answers on the 'OPEN' Framework
Year: 2024
Type: other
Abstract: International collaboration brings multiple benefits to regulatory authorities, and eventually to patients. It facilitates patient access through harmonisation or convergence, brings additional scientific expertise to the regulatory process, and simplification for the pharmaceutical industry. EMA began a pilot in December 2020 to increase international collaboration and share scientific expertise on the evaluation of COVID-19 vaccines and therapeutics. All COVID-19 vaccines and therapeutics ...
Source: OpenEdition (OpenEdition)
DOI: 10.58079/12ja7
Author: Vroby
Language: English
Topic: Healthcare Regulation
Subfield: Health Information Management
Field: Health Professions
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6955333802
Cites:
Cited by:
Related to: